Recent Developments in Smart Nanocarriers in Cancer Treatment

Abstract

Cancer is defined by uncontrolled cell growth that affects approximately 11 million people worldwide each year. Recent studies showed that traditional treatment approaches are quite insufficient to suppress tumor growth. New approaches are tried to develop for cancer treatment because the traditional treatment approaches are quite insufficient to suppress tumor growth. In this sense, it is necessary to develop nanocarrier systems that can carry more than one cargo molecules such as multiple-drug, gene, and biomarker. Thus, unlike traditional methods for more effective cancer treatment, incorporating both diagnostic and therapeutic functions into a single nanocarrier system has become the common topic of current studies. Hybrid nanoparticles, which can be called all-in-one systems, have a significant potential to perform such multiple functions. Here, we focused on the current progress in the design of hybrid nanocarriers for combined therapy that can harvest the synergistic effects of different treatments on a single platform.